Tempest Therapeutics, Inc.: Form 8-K, filed Jun 21, 2017
Filed with the SEC on Jun 21, 2017 and accepted by EDGAR at Jun 21, 2017, 16:07 ET.
Items reported
- Item 2.05 Exit or disposal costs
- Item 5.02 Departure or appointment of officers or directors
- Item 8.01 Other events
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001104659-17-040651. Last ingested by Listed: Nov 15, 2026, 00:20 ET. Listed shows no prices and gives no investment advice.